title: Summary of Breakout Session B: Regulatory Expectations for CGMP.
abstract: CONFERENCE PROCEEDING Proceedings of the PDA/FDA Adventitious Viruses in Biologics: Detection and Mitigation Strategies Workshop in Bethesda, MD, USA; December 1-3, 2010 Guest Editors: Arifa Khan (Bethesda, MD), Patricia Hughes (Bethesda, MD) and Michael Wiebe (San Francisco, CA).
authors.affiliation: Director, Division of Case Management, CBER, FDA.
authors.forename: Robert
authors.initials: R
authors.lastname: Sausville
authors.forename: Chantal
authors.initials: C
authors.lastname: Cazeault
mesh_terms: D001688:Biological Products; D015195:Drug Design; D006801:Humans; D012495:San Francisco; D014780:Viruses
chemical_list: D001688:Biological Products